---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-23-000049"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T09:16:41.698169+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Neurocrine CMO Eiry Roberts to retire in 2025; search underway

## Summary
- Chief Medical Officer Eiry W. Roberts, M.D., notified Neurocrine of her plan to retire in 2025 for personal reasons.
- Dr. Roberts will remain as CMO until her replacement is on-boarded; the company has initiated a search.
- Her retirement is not due to any disagreement with Neurocrine's operations, policies, or practices.

## SEC filing metadata
- accession: 0000914475-23-000049
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/0000914475-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/nbix-20230710.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-23-000049
- JSON: https://secwatch.observer/filing/0000914475-23-000049.json
- Plain text: https://secwatch.observer/filing/0000914475-23-000049.txt

## Key facts
- Executive change
  Eiry W. Roberts retired as Chief Medical Officer at NEUROCRINE BIOSCIENCES INC.
  - Action: retired
  - Role: Chief Medical Officer
  source text: On July 10, 2023, Eiry W. Roberts, M.D., notified Neurocrine Biosciences, Inc. (the “Company”) of her decision to retire in 2025 from her position as Chief Medical Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/0000914475-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.